Tag: industry

DIANT Pharma is moving into year five, and the LNP market is picking up. Let’s capitalize on that forward momentum in 2026. Check them out at www.diantpharma.com.

YourBio Health was purchased by Hims & Hers in 2025 from Flagship Pioneering. So, when your GLP-1 injections are virtually painless, these are the guys to thank. Check them out at www.yourbiohealth.com.

With $1.5 Billion raised, the FS2 team continues to expand and will launch its Wilmington, NC, facility in Q1 2026. Can’t wait to see the final product. Check them out at www.fs2.com.

Yourway continued to grow its privately held supply chain logistics business in 2025 and is always looking ahead. Keep doing what you’re doing in 2026. Check them out at www.yourway.com.

FAB Biopharma continues to look for investment, and we are in full support. Here’s to making great strides in women’s health in 2026. Check them out at www.fabbiopharma.com.

TriRx consolidated its business in 2025, and we are looking forward to spurring growth again in 2026, with Tim Tyson as the ever-strong CEO. Check them out at www.trirx.com.

The oncology market always has the highest investment in R&D; the Primira investment into ErgoMed and PrimeVigilance will capitalize on this. We wish Ergomed all the success in the world for 2026. Check them out at www.ergomedcro.com.

As part of our New Year’s wishlist, we wish Bio X Cell, led by one of our favorite CEOs, Chris Conway, continued double-digit growth in 2026. Check them out at www.bioxcell.com.

Ampersand Capital has been the leading PE in CDMO/CRO middle market investments for the past 10 years. That’s Nice looks to continue to support the team in 2026 and beyond. Check them out at www.ampersandcapital.com.

With a recent round of financing, CellFE continues to push against sector headwinds with great gusto. Our team is rooting for you guys in 2026. Check them out at www.cellfebiotech.com.